On April 21, 2026, Certara, Inc. agreed to sell its medical writing services to Veristat for $100 million, with potential additional earnings of up to $35 million based on performance.
AI Assistant
CERTARA INC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.